Literature DB >> 28444430

Successful treatment of a rare case of ameloblastic fibrosarcoma with radiation therapy.

Michael Oertel1, Gabriele Reinartz2, Sergiu Scobioala2, Hans Theodor Eich2.   

Abstract

Sarcomas are rare diseases of the head and neck region, representing around 1% of all malignancies. Amongst them, ameloblastic fibrosarcoma (AFS) is of even greater rarity, with less than 100 cases reported in the literature. Consequently, no standard treatment or guidelines have been made available. Surgery is often performed as primary therapy, but may be limited due to anatomical or functional reasons. We present a case of AFS successfully treated by postoperative radiation therapy. A detailed case study is provided, followed by a review of the English-language literature focusing on the role of radiation therapy.

Entities:  

Keywords:  Head and neck neoplasms; Organs at risk; Radiotherapy, intensity-modulated; Sarcoma; Surgery

Mesh:

Year:  2017        PMID: 28444430     DOI: 10.1007/s00066-017-1136-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  35 in total

Review 1.  Ameloblastic fibrosarcoma of the maxilla: report of a case.

Authors:  A S DeNittis; M D Stambaugh; C Looby
Journal:  J Oral Maxillofac Surg       Date:  1998-05       Impact factor: 1.895

2.  Ameloblastic fibrosarcoma arising de novo in the maxilla.

Authors:  Y Tajima; N Utsumi; S Suzuki; K Fujita; H Takahashi
Journal:  Pathol Int       Date:  1997-08       Impact factor: 2.534

3.  Ameloblastic sarcoma in the maxilla--a case report.

Authors:  D Hatzifotiadis; A Economou
Journal:  J Maxillofac Surg       Date:  1973-03

4.  Transformation of ameloblastic fibroma to fibrosarcoma.

Authors:  P A Reichart; H Zobl
Journal:  Int J Oral Surg       Date:  1978-10

Review 5.  Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature.

Authors:  Kazuo Kobayashi; Ryuichi Murakami; Tohru Fujii; Akiyoshi Hirano
Journal:  J Craniomaxillofac Surg       Date:  2005-10       Impact factor: 2.078

6.  Ameloblastic Fibrosarcoma of the Mandible With Distant Metastases.

Authors:  Fereydoun Pourdanesh; Mansoureh Mohamadi; Mohammad Moshref; Omid Soltaninia
Journal:  J Oral Maxillofac Surg       Date:  2015-07-11       Impact factor: 1.895

7.  Ameloblastic fibrosarcoma in the maxilla, malignant transformation of ameloblastic fibroma.

Authors:  Y Takeda; R Kaneko; A Suzuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Ameloblastic fibrosarcoma of the maxillary sinus in an infant: a case report with long-term follow-up.

Authors:  Nona Zabolinejad; Mehran Hiradfar; Kazem Anvari; Alale Shojae Razavi
Journal:  J Pediatr Surg       Date:  2008-02       Impact factor: 2.545

9.  Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.

Authors:  J Verweij; A van Oosterom; J-Y Blay; I Judson; S Rodenhuis; W van der Graaf; J Radford; A Le Cesne; P C W Hogendoorn; E D di Paola; M Brown; O S Nielsen
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  Ameloblastic fibrosarcoma: a rare malignant odontogenic tumor.

Authors:  S M Gilani; A Raza; B M Al-Khafaji
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2013-07-09       Impact factor: 2.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.